Axon Enterprise, Inc $AXON Shares Sold by Greenwich Wealth Management LLC

Greenwich Wealth Management LLC cut its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 0.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 26,899 shares of the biotechnology company’s stock after selling 100 shares during the period. Axon Enterprise comprises approximately 1.1% of Greenwich Wealth Management LLC’s holdings, making the stock its 14th biggest position. Greenwich Wealth Management LLC’s holdings in Axon Enterprise were worth $22,271,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of AXON. TCI Wealth Advisors Inc. bought a new position in shares of Axon Enterprise during the second quarter valued at approximately $214,000. Jaffetilchin Investment Partners LLC boosted its position in Axon Enterprise by 11.7% during the 2nd quarter. Jaffetilchin Investment Partners LLC now owns 5,938 shares of the biotechnology company’s stock valued at $4,916,000 after purchasing an additional 624 shares during the period. Vanguard Group Inc. grew its stake in Axon Enterprise by 3.5% during the 2nd quarter. Vanguard Group Inc. now owns 8,937,260 shares of the biotechnology company’s stock worth $7,399,515,000 after buying an additional 305,252 shares during the last quarter. Duncker Streett & Co. Inc. increased its position in Axon Enterprise by 3.2% in the second quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock worth $12,006,000 after buying an additional 448 shares during the period. Finally, EFG Asset Management North America Corp. lifted its stake in Axon Enterprise by 17.8% in the second quarter. EFG Asset Management North America Corp. now owns 12,701 shares of the biotechnology company’s stock valued at $10,511,000 after buying an additional 1,918 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on AXON. Barclays lowered their price target on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. The Goldman Sachs Group decreased their target price on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research report on Wednesday, November 5th. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Bank of America boosted their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Finally, Raymond James Financial restated an “outperform” rating and issued a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $814.00.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 77 shares of the company’s stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares of the company’s stock, valued at approximately $11,402,280. This represents a 0.51% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $591.04, for a total transaction of $5,910,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,023,982 shares in the company, valued at $1,787,294,321.28. This represents a 0.33% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 38,622 shares of company stock worth $26,439,364. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Up 1.3%

Axon Enterprise stock opened at $540.14 on Friday. Axon Enterprise, Inc has a 12-month low of $469.24 and a 12-month high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The stock has a market capitalization of $42.62 billion, a PE ratio of 133.37, a price-to-earnings-growth ratio of 29.49 and a beta of 1.45. The firm has a 50 day simple moving average of $658.44 and a 200-day simple moving average of $726.85.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The firm had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s revenue for the quarter was up 30.6% on a year-over-year basis. During the same quarter last year, the company earned $1.45 earnings per share. As a group, equities research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.